NAVEEN SHARMA

TitleInstructor
InstitutionMD Anderson
DepartmentImmunology
Address7455 Fannin St
Houston TX 77054-1901
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sultan H, Takeuchi Y, Ward JP, Sharma N, Liu TT, Sukhov V, Firulyova M, Song Y, Ameh S, Brioschi S, Khantakova D, Arthur CD, White JM, Kohlmiller H, Salazar AM, Burns R, Costa HA, Moynihan KD, Yeung YA, Djuretic I, Schumacher TN, Sheehan KCF, Colonna M, Allison JP, Murphy KM, Artyomov MN, Schreiber RD. Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy. Nature. 2024 Aug; 632(8023):182-191. PMID: 39048822; PMCID: PMC11291290.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    2. Sharma N, Fan X, Atolagbe OT, Ge Z, Dao KN, Sharma P, Allison JP. ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotype. J Exp Med. 2024 Apr 01; 221(4). PMID: 38517331; PMCID: PMC10959121.
      Citations: 1     Fields:    Translation:HumansCells
    3. Sharma N, Atolagbe OT, Ge Z, Allison JP. LILRB4 suppresses immunity in solid tumors and is a potential target for immunotherapy. J Exp Med. 2021 07 05; 218(7). PMID: 33974041; PMCID: PMC8117208.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    4. Sharma N, Allison JP, Vacher J. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proc Natl Acad Sci U S A. 2019 05 21; 116(21):10453-10462. PMID: 31076558; PMCID: PMC6534983.
      Citations: 21     Fields:    Translation:AnimalsCells
    5. Sharma N, Benechet AP, Lefran?ois L, Khanna KM. CD8 T Cells Enter the Splenic T Cell Zones Independently of CCR7, but the Subsequent Expansion and Trafficking Patterns of Effector T Cells after Infection Are Dysregulated in the Absence of CCR7 Migratory Cues. J Immunol. 2015 Dec 01; 195(11):5227-36. PMID: 26500349; PMCID: PMC4655190.
      Citations:    
    6. Src kinases central to T-cell receptor signaling regulate TLR-activated innate immune responses from human T cells. Innate Immunity. 22:238-244.
    7. CD8 T cells enter the splenic t cell zones independently of CCR7, but the subsequent expansion and trafficking patterns of effector t cells after infection are dysregulated in the absence of CCR7 migratory cues. Journal of Immunology. 195:5227-5236.
    SHARMA's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (42)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _